Clinical Trial Update: Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER® [Phase 3]

View source ↗

Summary

Phase 3 trial comparing budesonide/formoterol SPIROMAX inhalation powder to Symbicort Turbohaler in asthma; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SPIROMAX (budesonide/formoterol) inhalation powder (budesonide/formoterol)
• Symbicort Turbohaler (budesonide/formoterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2023-12-08